Aspartic protease 1 (Necator americanus) (Na-APR-1)

Necator americanus aspartic protease APR-1 (Na-APR-1) is a critical digestive enzyme localized in the gut epithelium of the adult human hookworm, where it initiates the proteolytic cascade required to degrade host hemoglobin for nutrient acquisition (nih.gov, 2015). This enzyme is a member of the cathepsin D-like aspartic protease family and is essential for the parasite's survival and ability to cause disease, specifically iron-deficiency anemia resulting from blood loss (nih.gov, 2022). Because of its critical role in hookworm metabolism, Na-APR-1 is a primary target for vaccine development, with the most advanced candidate being a catalytically inactive mutant known as Na-APR-1(M74) (researchgate.net, 2022). Vaccination with Na-APR-1(M74) aims to induce neutralizing IgG antibodies that bind to the native enzyme in the parasite's gut, inhibiting its function and leading to worm starvation and reduced egg production (bioworld.com, 2016). The vaccine-induced antibodies interfere with the worm's blood feeding, thereby impairing its growth and fecundity while reducing the overall parasite burden in the host (nih.gov, 2015). Clinical trials have demonstrated that Na-APR-1-based vaccines are safe and immunogenic, often co-administered with other antigens like Na-GST-1 to enhance protective efficacy (contagionlive.com, 2020).

Other names

Na-APR-1Necator americanus hemoglobinaseAPR-1Aspartic protease APR-1Na-APR-1(M74)

Induction of neutralizing IgG antibodies that inhibit the enzymatic activity of the parasite's hemoglobinase, leading to starvation and reduced viability of the hookworm.